News & Insights
Early-Stage Life Sciences Has More to Lose from Storage Blind Spots Than Big Pharma
Early-Stage Life Sciences Has More to Lose from Storage Blind Spots Than Big Pharma
In early-stage life sciences, fewer materials don’t mean lower risk. They mean less margin for error. When...
Why Storage Minimums and Transfer Barriers Are a Hidden Tax on Early Stage Life Sciences Innovation
Why Storage Minimums and Transfer Barriers Are a Hidden Tax on Early Stage Life Sciences Innovation
Early-stage life sciences operates under a single constraint: capital must move science forward. Yet many storage...
GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors
GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors
GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors Veteran...
Turning Storage into Strategy — The Real-World Value of ISO 20387 Certification
Turning Storage into Strategy — The Real-World Value of ISO 20387 Certification
Turning Storage into Strategy — The Real-World Value of ISO 20387 Certification In regulated science, storage has...
Engineering the Future of Biobanking
Engineering the Future of Biobanking
Engineering the Future of Biobanking — How GXP-Guardian® Transforms Compliance into Intelligence In the life...
Top 3 Key Takeaways from RQA 2025 Conference
Top 3 Key Takeaways from RQA 2025 Conference
Top 3 Key Takeaways from RQA 2025 Conference Contributed by: Kate Peters, Director, Quality Assurance Last week,...